Secondary Cytoreduction and Carboplatin Hyperthermic Intraperitoneal Chemotherapy for Platinum-Sensitive Recurrent Ovarian Cancer: An MSK Team Ovary Phase II Study

John Paul Diaz; Eric Schroeder

Secondary Cytoreduction and Carboplatin Hyperthermic Intraperitoneal Chemotherapy for Platinum-Sensitive Recurrent Ovarian Cancer: An MSK Team Ovary Phase II Study

Miami Cancer Institute

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Journal of Clinical Oncology
Volume	39
State	Published - Aug 10 2021

Access to Document

ViewcontentFinal published version, 20.4 KBLicense: Unspecified

Cite this

@article{68883485bd6b4657b8f81113e01ca307,

title = "Secondary Cytoreduction and Carboplatin Hyperthermic Intraperitoneal Chemotherapy for Platinum-Sensitive Recurrent Ovarian Cancer: An MSK Team Ovary Phase II Study",

author = "Diaz, {John Paul} and Eric Schroeder",

note = "Journal of Clinical Oncology (2021) 39(23):2594-2604",

year = "2021",

month = aug,

day = "10",

language = "American English",

volume = "39",

journal = "Journal of Clinical Oncology",

}

TY - JOUR

T1 - Secondary Cytoreduction and Carboplatin Hyperthermic Intraperitoneal Chemotherapy for Platinum-Sensitive Recurrent Ovarian Cancer: An MSK Team Ovary Phase II Study

AU - Diaz, John Paul

AU - Schroeder, Eric

N1 - Journal of Clinical Oncology (2021) 39(23):2594-2604

PY - 2021/8/10

Y1 - 2021/8/10

UR - https://scholarlycommons.baptisthealth.net/se-all-publications/3964

M3 - Article

VL - 39

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

ER -

Secondary Cytoreduction and Carboplatin Hyperthermic Intraperitoneal Chemotherapy for Platinum-Sensitive Recurrent Ovarian Cancer: An MSK Team Ovary Phase II Study

Access to Document

Other files and links

Cite this